Compare HNI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HNI | QURE |
|---|---|---|
| Founded | 1944 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | N/A | 2007 |
| Metric | HNI | QURE |
|---|---|---|
| Price | $41.08 | $22.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | ★ $70.00 | $58.55 |
| AVG Volume (30 Days) | 962.7K | ★ 2.4M |
| Earning Date | 10-28-2025 | 11-10-2025 |
| Dividend Yield | ★ 3.27% | N/A |
| EPS Growth | ★ 16.22 | N/A |
| EPS | ★ 2.98 | N/A |
| Revenue | ★ $2,593,100,000.00 | $15,751,000.00 |
| Revenue This Year | $5.68 | N/A |
| Revenue Next Year | $3.52 | $158.05 |
| P/E Ratio | $13.97 | ★ N/A |
| Revenue Growth | ★ 1.15 | N/A |
| 52 Week Low | $38.04 | $7.76 |
| 52 Week High | $54.84 | $71.50 |
| Indicator | HNI | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 34.50 |
| Support Level | $40.13 | $19.29 |
| Resistance Level | $44.42 | $28.50 |
| Average True Range (ATR) | 1.19 | 1.38 |
| MACD | 0.14 | 0.44 |
| Stochastic Oscillator | 25.29 | 28.88 |
HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.